Acer Therapeutic

ACER NASDAQ
4.120
-15.160
-78.63%
盘后: 4.190 +0.07 +1.70% 19:59 06/25 EDT
开盘
5.34
昨收
19.28
最高
5.34
最低
3.826
成交量
549.10万
成交均量(3M)
16.02万
52周最高
34.10
52周最低
3.826
换手率
54.43%
市值
4,155.99万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Acer Therapeutic ACER股票价格,Acer Therapeutic股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The Company is developing Edsivo for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the United States. The Company is developing ACER-001, a pharmacologic treatment option for the treatment of Maple Syrup Urine Disease (MSUD). ACER-001 is an immediate-release formulation of sodium phenylbutyrate (NaPB) developed using a microencapsulation process. The Company is also developing ACER-001 for the treatment of Urea Cycle Disorders (UCD).
展开 >

最近浏览

名称
价格
涨跌幅